Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
12/16/1992 | EP0517850A1 Compositions and methods of treatment of sympathetically maintained pain |
12/16/1992 | EP0517812A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
12/16/1992 | EP0517787A1 Method of treating therapy-resistant schizophrenia with amperozide |
12/16/1992 | CN1019486B Process for preparation of gamma-butyrolactams |
12/16/1992 | CN1019451B Cycioalkyliamides of (8beta)-1-alkyl-6-(substituted) ergolines |
12/16/1992 | CA2089569A1 3-aryl or 3-heteryl-.beta.-carbolines, their production and use in pharmaceutical agents |
12/15/1992 | US5171747 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy |
12/15/1992 | US5171571 Effervescent tablet |
12/15/1992 | CA2071181A1 Benzodiazepine analogs |
12/15/1992 | CA2071092A1 1,4-benzodiazepines with 5-membered heterocyclic rings |
12/15/1992 | CA1311487C Derivatives of 1-benzyl-2-oxo-5-alcoxypyrrolidine, a process for their preparation and compositions containing them |
12/15/1992 | CA1311479C Derivatives of quinuclidine spiro (1,3-oxathiolane-5,3-) quinuclidine compounds |
12/15/1992 | CA1311419C Utilization of otilonium bromide for topical application in the gastrointestinal tract and pharmaceutical formulations appropriate for such use |
12/15/1992 | CA1311417C Antidiabetic composition comprising 7-thiaprostaglandin e _or its derivative |
12/14/1992 | CA2071105A1 Nucleotide sequences |
12/10/1992 | WO1992021680A1 Aza-6-indole-derived compounds as benzodiazepine receptor ligands and drugs containing same |
12/10/1992 | WO1992021654A2 Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives |
12/10/1992 | WO1992021648A1 Amino acid derivative anticonvulsant |
12/10/1992 | WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
12/10/1992 | WO1992021339A1 Isoxazole and isothiazole compounds that enhance cognitive function |
12/10/1992 | WO1992021337A1 Methods of treating injury to the central nervous system |
12/10/1992 | WO1992019617A3 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
12/10/1992 | WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
12/10/1992 | DE4118741A1 Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln New hetaryloxy (beta) carbolines, their production and use in pharmaceutical preparations |
12/10/1992 | CA2110299A1 Compounds derives from aza-6-indoles, benzodiazepine receptor ligands and drugs containing same |
12/09/1992 | EP0517589A2 Tachykinin derivatives, their preparation and pharmaceutical compositions containing them |
12/09/1992 | EP0517484A2 Fermentation analogs of virginiamycin M1 |
12/09/1992 | EP0517464A1 Peptides useful in regulating the immune and nervous systems |
12/09/1992 | EP0517347A1 New combinations for the treatment of Parkinsons disease, containing NMDA-antagonists |
12/09/1992 | EP0517221A1 [(Arylalkylpiperidine-4-yl)methyl]-2-alpha,3,4,5-tetrahydro-1(2H)-acenaphthylene-1-ones and related compounds, a process for their preparation and their use as medicaments |
12/09/1992 | EP0516980A1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors |
12/09/1992 | EP0516978A1 Enantiomers of substituted (aminophenyl)-heteroarylethylamines, a method for their preparation, and pharmaceutical compositions containing these compounds |
12/09/1992 | EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof |
12/09/1992 | EP0516914A2 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation |
12/09/1992 | EP0516795A1 Use of quisqualate-receptor antagonists for treating parkinson's disease |
12/09/1992 | EP0516777A1 Brain resuscitation device and method |
12/09/1992 | EP0516748A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists |
12/09/1992 | CN1066848A Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents |
12/09/1992 | CN1019393B Substituted n-((4-piperidingl) alkyl) bicyclic condensed oxazol and thiazolaminer |
12/09/1992 | CN1019388B Process for preparing n-alkylsulfurylanilline derivatives |
12/08/1992 | US5169947 Therapy for obesity, depression |
12/08/1992 | US5169868 Antidepressants, enzyme inhibitors; alleviating parkinsonism, alzheimer's disease |
12/08/1992 | US5169856 Cholinesterase antagonists |
12/08/1992 | US5169855 Piperidine ether derivatives as psychotropic drugs or plant fungicides |
12/08/1992 | US5169845 Piperazine derivatives |
12/08/1992 | US5169764 Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras |
12/08/1992 | CA2070714A1 ¬(arylalkylpiperidin-4-yl)methyl|-2a,3,4,5-tetrahydro-1(2h) -acenaphthylen-1-ones and related compounds (case hoe 91/s 013/hr-1223) |
12/08/1992 | CA2059701A1 Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation |
12/06/1992 | WO1992021679A1 NEW HETERO-ARYLOXY-β-CARBOLINES, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS |
12/06/1992 | CA2087098A1 Hetero-aryloxy-.beta.-carbolines, their preparation and their use in medicamens |
12/06/1992 | CA2070526A1 Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and pharmaceutical compositions containing them |
12/06/1992 | CA2070494A1 Combination preparations for treatment of parkinson's disease |
12/06/1992 | CA2070055A1 Excitatory amino acid receptor antagonists and methods for the use thereof |
12/05/1992 | CA2070331A1 Tachykinin denved peptides and pseudopeptides, process for their preparation and pharmaceutical compositions containing them |
12/04/1992 | WO1992021366A1 Immunoregulatory and neuroregulatory pentapeptides |
12/04/1992 | CA2088664A1 Immunoregulatory and neuroregulatory pentapeptides |
12/04/1992 | CA2070242A1 Fermentation analogs of virginiamycin m1 |
12/02/1992 | EP0516520A1 1,4-Disubstituted piperidines, their preparation and therapeutical application |
12/02/1992 | EP0516392A2 Naphthyridine derivatives as angiotensin II inhibitors |
12/02/1992 | EP0516350A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists |
12/02/1992 | EP0516349A2 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists |
12/02/1992 | EP0516297A1 Pyridazinediones and their use in the treatment of neurological disorders |
12/02/1992 | EP0516234A1 Phenoxyphenyl derivatives |
12/02/1992 | EP0516132A1 Anti-neuronotoxic activity and therapeutic applications of GM1 ganglioside methyl ester |
12/02/1992 | EP0515866A1 Use of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide for the treatment of dementia |
12/02/1992 | EP0515535A1 Angiotensin ii antagonists incorporating a substituted benzyl element |
12/02/1992 | EP0294441B1 Composition to prevent seasickness |
12/02/1992 | CN1066654A Benzofuran derivatives |
12/01/1992 | WO1992021677A1 bibNUCLIDINE DERIVATIVES |
12/01/1992 | WO1992021671A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof |
12/01/1992 | US5168103 Neuroprotectants, anticonvulsants |
12/01/1992 | US5168099 Optically active alkylenedioxybenzene derivatives and their use in therapy |
12/01/1992 | CA2102109A1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1, 4-benzodioxine and the process of preparation thereof |
12/01/1992 | CA2070124A1 Uses of a ganglioside derivative |
12/01/1992 | CA2068946A1 Heterocyclic derivatives |
12/01/1992 | CA1310973C .beta.-(FLUOROMETHYLENE)-5-HYDROXYTRYPTOPHAN AND DERIVATIVES AS PRODRUGS FOR MAO INHIBITION |
12/01/1992 | CA1310968C Indole derivatives |
12/01/1992 | CA1310966C Substituted 1-(h-imidazol-4-yl)alkyl-benzamides |
12/01/1992 | CA1310965C Indolizine derivatives, process for preparing them and the compositions containing them |
12/01/1992 | CA1310911C Essential fatty acid compositions |
12/01/1992 | CA1310910C Medicament preparations containing etofenamate and dimethyl sulphoxide |
11/30/1992 | CA2068373A1 Phenoxypenyl derivatives |
11/29/1992 | CA2068378A1 Chemical compounds |
11/29/1992 | CA2068377A1 Chemical compounds |
11/26/1992 | WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY |
11/26/1992 | WO1992020749A1 Water-based recording ink |
11/26/1992 | WO1992020709A1 Galanin antagonist |
11/26/1992 | WO1992020706A1 Endothelin antagonists |
11/26/1992 | WO1992020679A1 Benzofuran derivatives |
11/26/1992 | WO1992020674A1 1h-imidazol-1-yl-methyl benzofuran derivatives, with the imidazolyl moiety being substituted by a cycloalkyl group |
11/26/1992 | WO1992020673A1 Antihypotensive benzofuran derivatives with n-linked 1h-imidazolylmethyl-5-carboxamide substituents |
11/26/1992 | WO1992020658A1 Novel heterocyclic carboxylic acids |
11/26/1992 | WO1992020657A1 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists |
11/26/1992 | WO1992020655A1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives |
11/26/1992 | WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
11/26/1992 | WO1992020334A1 Pharmaceutical composition comprising ibuprofen salt |
11/26/1992 | WO1992020328A2 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression |
11/26/1992 | CA2109503A1 Galanin antagonist |
11/26/1992 | CA2108754A1 Endothelin antagonists |